ACRV vs AMGN: Which Stock is Better?

Side-by-side comparison of Acrivon Therapeutics Inc and Amgen Inc in 2026

Comparison Updated:

ACRV

Acrivon Therapeutics Inc

$1.96

AMGN

Amgen Inc

$331.00

Key Metrics Comparison

MetricACRVAMGNWinner
Market Cap$61.85M$178.24BAMGN
P/E RatioN/A25.58AMGN
EPS (TTM)$N/A$12.94AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin0.0%70.1%AMGN

Analyze ACRV

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ACRV or AMGN a better investment?

Comparing ACRV and AMGN: Acrivon Therapeutics Inc has a market cap of $61.85M while Amgen Inc has $178.24B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ACRV and AMGN?

ACRV (Acrivon Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ACRV or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ACRV or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for ACRV.

Which company is more profitable: ACRV or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.1% compared to 0.0% for ACRV.

Which is the larger company: ACRV or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $178.24B compared to $61.85M for ACRV.

Should I buy ACRV or AMGN in 2026?

Both ACRV and AMGN have investment merit. ACRV trades at $1.96 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ACRV and AMGN stock?

Key differences: Market Cap ($61.85M vs $178.24B), P/E Ratio (N/A vs 25.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.1%).

Popular Stock Comparisons